APPLICATION
ANDA207398
TYPE
ANDA
ORIGINAL APPROVAL
2018-07-05
LATEST ACTION
2022-01-12
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
AZITHROMYCINPrescription
AZITHROMYCIN EQ 500MG BASE · TABLET · ORAL
Approval history
2022-01-12Labeling · Supplement 9 · standardAP
2020-05-14Labeling · Supplement 4 · standardAP
2018-07-05UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.